Factors associated with mortality in ventilator associated pneumonia of multidrug resistant acinetobacter baumannii Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Methicillin-resistant staphylococcus aureus: The most prevalent cause of ventilator associated pneumonia in Tehran hospitals Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
Bundles for the prevention of ventilator-associated pneumonia in a Brazilian hospital Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Implications of identifying the pathogen in ventilator-associated pneumonia (VAP) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013
ICU acquired pneumonia due to pseudomonas aeruginosa with and without multidrug resistance Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014
Ventilator-associated pneumonia (VAP) – Early and late-onset differences Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013
Direct LAMP assay from clinical sample for carbapenem resistant A. baumannii Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Ventilator-associated pneumonia (VAP) pathogenic microorganisms eradication and persistence during antimicrobial therapy Source: Annual Congress 2013 –Recent developments in pneumonia Year: 2013
Multidrug resistant acinetobacter baumanii pneumonia: Mortality analysis and comparison of intravenous versus aerosolized therapy Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Physical deterioration during hospitalization in patients with community-acquired pneumonia Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions Year: 2015
Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013
Frequency of multidrug resistant pathogens in healthcare associated pneumonia Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP) Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Microbiological vs non-microbiological confirmed nnventilator ICU-acquired pneumonia Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016
Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015
Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
Rapid quantification of bacteria associated to ventilator associated pneumonia in endotracheal aspirate specimens Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014
Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients Source: International Congress 2016 – Sepsis and ARDS: looking forward Year: 2016
Prognostic factors of the patients admitted to intensive care unit with nursing and healthcare-associated pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Relation between bacteremia and septic shock in patients with pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013